Alberto Puccini
University of Southern California
H-index: 25
North America-United States
Top articles of Alberto Puccini
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting | Virchows Archiv: an international journal of pathology | Federica Grillo Valentina Angerilli Paola Parente Alessandro Vanoli Claudio Luchini | 2024/1/17 |
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset | ESMO open | MM Germani G Vetere F Santamaria R Intini F Ghelardi | 2024/4/1 |
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center | European Journal of Cancer Prevention | Alberto Puccini Simone Nardin Lucia Trevisan Sonia Lastraioli Viviana Gismondi | 2024/1/9 |
Development and validation of an artificial-intelligence-based pathomics biomarker to predict resistance to first-line treatment in metastatic colorectal cancer | Cancer Communications | Quirino Lai Carmine De Stefano Jean Emond Prashant Bhangui Toru Ikegami | 2023/12 |
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer | Histopathology | Federica Grillo Michele Paudice Simona Pigozzi Maria Dono Sonia Lastraioli | 2024/1/3 |
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients | ESMO Gastrointestinal Oncology | A Puccini F Grillo M Fassan S Lonardi M Genuardi | 2024/3/1 |
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention | Arianna Dal Buono Alberto Puccini Gianluca Franchellucci Marco Airoldi Michela Bartolini | 2024/2/20 | |
Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence? | Erika Stucchi Michela Bartolini Marco Airoldi Roberta Fazio Valentina Daprà | 2024/4/4 | |
223P Artificial intelligence-based pathomics biomarker predict primary resistance to first-line treatment in metastatic colorectal cancers | Annals of Oncology | G Mauri V Giannini G Nicoletti L Lazzari A Sartore Bianchi | 2023/10/1 |
ctDNA to guide treatment of colorectal cancer: ready for standard of care? | Alberto Puccini Valentino Martelli Alessandro Pastorino Stefania Sciallero Alberto Sobrero | 2023/2 | |
Prognostic impact of depth of response (DpR) and early tumour shrinkage (ETS) in patients (pts) with BRAF V600E mutated (mut) metastatic colorectal cancer (mCRC) receiving … | Guglielmo Vetere Marco Maria Germani Maria Bensi Carlotta Antoniotti Sara Lonardi | 2023/6/1 | |
1635P Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic ductal adenocarcinoma patients | Annals of Oncology | G Orsi C Carconi P Ghiorzo L Pastorino M Chiaravalli | 2023/10/1 |
New therapeutic approaches in microsatellite stable colorectal cancer patients | Frontiers in Oncology | Michela Bartolini Andreas Seeber Alberto Puccini | 2023 |
Correlation of comprehensive molecular mapping of pancreatic ductal adenocarcinoma with XPO1 mRNA expression levels to potential clinical targets. | Andreas Seeber Rebecca Gruber Florian Kocher Kai Zimmer Alberto Puccini | 2023/6/1 | |
# 412 Pembrolizumab in metastatic cancer patients with microsatellite instability: subgroup analysis on endometrial cancer patients, results from a single center study | Silvia Puglisi Malvina Cremante Agostina Lagodin D’Amato Fabio Catalano Annalice Gandini | 2023/9/1 | |
The controversial abscopal effect: A single-center experience about the combination of stereotactic radiotherapy with pembrolizumab in patients with metastatic dMMR/MSI-H … | Annalice Gandini Valentino Martelli Liliana Belgioia Silvia Puglisi Malvina Cremante | 2023/6/1 | |
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system | NPJ precision oncology | Kai Zimmer Florian Kocher Gerold Untergasser Brigitte Kircher Arno Amann | 2023/7/3 |
Exploring the nuances between BRCA1 and BRCA2: A multiomic analysis (1295) | Gynecologic Oncology | John Wallbillich Radhika Gogoi Sharon Wu Alex Farrell Seongho Kim | 2023/9/1 |
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting | Virchows Archiv | Federica Grillo Valentina Angerilli Paola Parente Alessandro Vanoli Claudio Luchini | 2023/12/23 |
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives | Annalice Gandini Silvia Puglisi Chiara Pirrone Valentino Martelli Fabio Catalano | 2023/5/3 |
Co-Authors
